Logout
 
 Welcome
 About CHEST 2008
 CME Information
 Education Program
 Search All Sessions
 Postgraduate Courses
 ACCP Simulation Center
 Non-CME Programs
 Morning Education
 Symposia
 Additional Programs
 Other Opportunities
 Guest Tour
 Asthma Coalition
 Exhibit Hall
 Industry & Exhibitors
 Hotel Information
 Travel Information
   International Travelers
 About Philadelphia
 Register
 CHEST 2008 Press Room
 Abstracts & Case Reports
 Future CHEST Meetings
 Past Meeting Content
 
 

Non-CME Promotional Programs
Evening Opportunities at CHEST 2008

Attend industry-sponsored evening programs to hear presentations of therapeutic topics, posters, cases, and equipment demonstrations. Sessions are open to all attendees and may include refreshments and food.

Monday, October 27
6:00 pm – 10:00 pm

Marriott Downtown

Eisai, Inc.
Framing DVT: A Fresh Perspective on Thrombosis

Presented in a gallery setting, attendees will take a tour through a collection of posters displaying clinical data on low-molecular-weight heparin. Several renowned experts will speak at the event and offer what promises to be a highly enlightening question and answer session. Attendees also will enjoy a light meal and refreshments.

MD Primer, Inc.
Pulmonary Dilemmas: Vignettes in Three Challenging Pulmonary Diseases

Agenda:
Challenges in Interstitial Lung Disease
Paul Noble, MD, FCCP

Pulmonary Arterial Hypertension: Where Are We in 2008?
Richard Channick, MD, FCCP

The Pulmonary Arterial Hypertension Quality Enhancement Research Initiative: Do Guidelines Affect Clinical Practice?
Valerie McLaughlin, MD

Acute Pulmonary Embolism: When Should We Get Aggressive?
Victor Tapson, MD, FCCP

There is a number of challenging dilemmas in pulmonary medicine that frequently vex the clinician, which include interstitial lung disease, pulmonary arterial hypertension, and venous thromboembolism. Our goal will be to offer a concise overview of each of these potentially fatal entities and leave attendees with insights that will help with the management of these patients. Presentation of recent data and reinforcement of less recent, but crucial, information also will be provided.

sanofi-aventis
Deep Venous Thrombosis and Pulmonary Embolism Quality Measures: What Happens if You Don’t Make the Leap?

At this non-CME event, commercially supported by sanofi-aventis, the new Joint Commission/National Quality Forum standards for DVT and appropriate DVT/PE prophylaxis will be discussed. The symposium features a DVT/PE health-care quality overview, appropriate DVT/PE prophylaxis, and action planning for your hospital. Faculty speakers are Samuel Z. Goldhaber, MD, FCCP; Darrell W. Harrington, MD; and Frank A. Michota, Jr., MD.

Sepracor, Inc.
Guideline-Based Management of Respiratory Disease

This program will provide a brief overview of COPD and asthma disease states and the management of these diseases according to internationally recognized guidelines. In addition, you will learn about a novel approach for using harmonicas to benefit the health of patients with respiratory diseases.

Topics that will be discussed in detail include:

  • Short-Acting Beta-Agonist for Asthma and COPD
  • Long-Acting Beta-Agonist for COPD
  • NEW Inhaled Corticosteroids for Persistent Asthma and Seasonal and Perennial Allergic Rhinitis

SonoSite
Experience the Difference: An Evening of Ultrasound Innovation With SonoSite

On behalf of SonoSite, you are cordially invited to participate in an evening of clinical and technology trends in hand-carried ultrasound and their impact on medical practice at the point of patient care. The event will provide an opportunity for a lively exchange of information and ideas on topics including critical care ultrasound applications, patient safety, implementation, and reimbursement. There also will be a Question and Answer Corner with the experts! Want more? The evening will be completed with SonoSite technology exhibits and scanning demonstrations. Come experience the difference! Hors d'oeuvres and refreshments will be served.

Tuesday, October 28
6:00 pm – 10:00 pm

Marriott Downtown

AstraZeneca LP
More details to follow

Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.
COPD: What Are the Next Questions We Should Be Asking To Improve the Care of Our Patients? An Expert Panel Offers Insights Into Effective Treatment

In this non-CME symposium, an expert panel of national thought leaders will explore critical components and questions regarding the long-term management of patients with COPD, which include hyperinflation, the impact of deconditioning and activity limitation, the importance of pulmonary rehabilitation, and benefits of pharmacologic treatment.

Edwards Lifesciences, LLC
An Interactive Evening Discussing Critical Cases

A panel of experts from multiple disciplines will discuss cases related to patients who are critically ill. Relevant cases and topics include determining fluid maximization strategies, methods used to determine preload responsiveness, the use of hemodynamic parameters to differentiate various shock states, applying concepts related to early goal-directed therapies, and indications for less-invasive monitoring. The evening includes interactive methods in which the participants are engaged with the expert panel.

Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc
DORIBAX Poster Dessert Reception

A dessert reception will highlight select global and national posters presented on DORIBAX from 2006 to 2008.

Approximately 175 to 250 registered CHEST attendees will be invited to the event.

Prior to the CHEST meeting, a notification will be sent to key opinion leaders registered for CHEST (based on the registration list provided by ACCP) via e-mail or a postal mailing, which announces the poster dessert reception event.

Approximately 25 posters from CHEST will be displayed in the event space for attendee viewing and discussion.

This event will be take place during the entire 4-hour time slot, and attendees can come and go at their own discretion.

Dessert and beverages will be provided by the contracted hotel.

United Therapeutics
Pulmonary Arterial Hypertension: The Great Debate

There are many opinions about pulmonary arterial hypertension (PAH) and its treatments. Listen as “party leaders” make their cases during a symposium sponsored by United Therapeutics titled, “PAH: The Great Debate.” The format for this timely, election-style debate symposium will be unlike anything you’ve seen before. You will participate in grilling the candidates and select the most compelling arguments for either status quo or change. PAH heavyweights will present the data, dispute the claims, and rebut the opposition. We live in a democratic society, so you will be asked to vote on the arguments throughout the meeting. Watch the sparks fly on October 28, 2008, from 6:00 pm to 10:00 pm. Remember, every vote counts!